CITIGROUP INC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 70 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$143
-92.8%
98
-82.2%
0.00%
Q3 2022$2,000
-50.0%
551
-47.3%
0.00%
Q2 2022$4,000
-63.6%
1,046
-55.5%
0.00%
Q1 2022$11,000
-70.3%
2,353
-76.8%
0.00%
Q4 2021$37,000
+8.8%
10,137
+141.0%
0.00%
Q3 2021$34,000
+47.8%
4,206
+109.6%
0.00%
Q2 2021$23,000
-92.6%
2,007
-94.0%
0.00%
Q1 2021$311,00033,5940.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$1,096,6370.23%
Aisling Capital Management LP 288,571$458,8280.22%
BVF INC/IL 3,614,662$5,747,3130.21%
Rubric Capital Management LP 1,487,385$2,364,9420.06%
HAMILTON LANE ADVISORS LLC 35,791$570.02%
MAI Capital Management 379,468$603,3540.01%
Laurion Capital Management LP 698,000$1,109,8200.01%
TRUST CO OF TOLEDO NA /OH/ 28,000$44,5200.01%
RP Management, LLC 3,700$5,8830.01%
Jasper Ridge Partners, L.P. 92,939$147,7730.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders